Advertisement
Screener

Twist Bioscience Corporation (TWST) ROI

Twist Bioscience Corp ROI

Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Twist Bioscience Corp roi for the quarter ending 2020-12-31 was -18.26%, a change of 109.53% year-over-year.
  • Twist Bioscience Corp roi for the quarter ending 2020-09-30 was -41.04%, a change of 26.34% year-over-year.
  • Twist Bioscience Corp roi for the quarter ending 2020-06-30 was -41.41%, a change of 10.79% year-over-year.
  • Twist Bioscience Corp roi for the quarter ending 2020-03-31 was -54.17%, a change of 14.83% year-over-year.
  • Twist Bioscience Corp roi for fiscal 2020 was -41.04%, a change of 26.34% from fiscal 2019.
  • Twist Bioscience Corp roi for fiscal 2019 was -67.37%, a 281.30% decline from fiscal 2018.
  • Twist Bioscience Corp roi for fiscal 2018 was 37.16%.
Available history
2018-09-30 to 2020-12-31
Data captured

Historical ROI

DateROINet income 12 monthNet income 3 monthDebt plus equity
2020-12-31-18.26%-$117.19M-$32.90M$641.91M
2020-09-30-41.04%-$139.93M-$24.32M$341M
2020-06-30-41.41%-$146.79M-$28.21M$354.45M
2020-03-31-54.17%-$146.5M-$31.77M$270.46M
2019-12-31-127.78%-$140.67M-$55.64M$110.08M
2019-09-30-67.37%-$107.67M-$31.18M$159.82M
2019-06-30-52.20%-$96.29M-$27.92M$184.46M
2019-03-31-69.00%-$86M-$25.93M$124.64M
2018-12-31-51.83%-$76.94M-$22.64M$148.46M
2018-09-3037.16%-$71.24M-$19.80M-$191.7M

Annual ROI

DateROINet income 12 monthDebt plus equity
2020-09-30-41.04%-$139.93M$341M
2019-09-30-67.37%-$107.67M$159.82M
2018-09-3037.16%-$71.24M-$191.7M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78